Related Experiment Videos
Delayed post-myocardial infarction invasive measures, helpful or harmful? A subgroup analysis
Hon-Kan Yip1, Chiung-Jen Wu, Cheng-Hsu Yang
1Division of Cardiology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Republic of China.
Chest
|July 14, 2004
Summary
Percutaneous coronary intervention (PCI) is safe and effective for early or recent myocardial infarction (MI), showing sustained clinical benefits. However, advanced congestive heart failure and old age predict poorer long-term outcomes in MI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Primary percutaneous coronary intervention (PCI) improves outcomes in acute myocardial infarction (MI).
- The efficacy of routine PCI in early or recent MI (within 7-30 days) remains less established.
- This study evaluated PCI's impact and identified predictors of outcomes in these patients.
Purpose of the Study:
- To assess the impact of PCI on clinical outcomes in patients with early or recent MI.
- To identify predictors of failed reperfusion after PCI.
- To determine prognostic factors influencing mortality in this patient cohort.
Main Methods:
- Prospective observational study of 377 patients undergoing PCI for early or recent MI.
- Logistic regression analysis to identify predictors of reperfusion failure and mortality.
- Long-term follow-up including coronary angiography and clinical outcomes assessment.
Main Results:
- Successful reperfusion achieved in 90.2% of patients.
- Predictors of failed reperfusion included high thrombus burden, early PCI (<4 days), advanced congestive heart failure (CHF), and diabetes.
- 30-day mortality was 6.8%, with advanced CHF, failed reperfusion, early PCI, and multivessel disease as independent predictors.
- Long-term mortality was predicted by advanced CHF and older age (>70 years).
- Left ventricular ejection fraction (LVEF) significantly improved post-PCI.
Conclusions:
- PCI is safe and successful for early/recent MI, even when performed later (>= day 4).
- Successful PCI demonstrates sustained clinical benefits with a relatively low mortality rate during long-term follow-up.
- Advanced CHF and advanced age remain significant predictors of poor prognosis in MI patients post-PCI.